Pfizer Inc. (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX) announced the completion of the Phase 3 clinical trial of their
Pfizer concludes COVID-19 vaccine trial with efficacy of 95%; will apply for EUA within days
Categories
pharmaceuticals
Can COVID vaccine be a panacea for Novavax’s (NVAX) growth needs?
The market has been closely following the activities of leading biopharma companies for some time, looking for updates on their COVID vaccine
Biogen (BIIB) might need to revisit pipeline after Alzheimer’s drug setback
The controversy surrounding biotechnology firm Biogen's (NASDAQ: BIIB) Alzheimer's drug Aducanumab took a positive turn last week after the FDA issued a
Affimed N.V. (AFMD) Q3 2020 Earnings Call Transcript
Affimed N.V. (NASDAQ: AFMD) Q3 2020 earnings call dated Nov. 10, 2020 Corporate Participants: Alexander Fudukidis -- Head of Investor Relations Adi Hoess -- Chief Executive
Pfizer (PFE) gains on data showing 90% efficacy for COVID-19 vaccine candidate
Shares of Pfizer Inc. (NYSE: PFE) rallied on Monday after the company reported positive results from its Phase 3 trial for its
Infographic: Highlights of Aurora Cannabis’ (ACB) Q1 2021 earnings report
Aurora Cannabis, Inc. (NYSE: ACB) reported a loss for the first quarter of 2021, continuing the recent trend. However, the bottom-line performance
Infographic: Highlights of Cronos Group (CRON) Q3 2020 earnings report
Marijuana company Cronos Group Inc. (NASDAQ: CRON) on Thursday reported financial results for the third quarter of 2020. Revenues increased by 96%,
Bristol-Myers Squibb beats in Q3, raises guidance
Bristol-Myers Squibb Company (NYSE: BMY) reported third-quarter 2020 financial results before the market opened on Thursday. The pharmaceutical company reported a 75%
GW Pharmaceuticals stock jumps 20% on Epidiolex strength
GW Pharmaceuticals (NASDAQ: GWPH) reported third-quarter 2020 financial results before the regular trading hours on Tuesday. The company, which specializes in cannabinoid
AbbVie (ABBV) to focus more on pipeline as recovery gathers pace
AbbVie, Inc. (NYSE: ABBV) has been recovering steadily from the virus-related slowdown and latest statistics show that the company's performance has improved
Eagle Pharmaceuticals Inc. (EGRX) Q3 2020 Earnings Call Transcript
Eagle Pharmaceuticals Inc. (NASDAQ: EGRX) Q3 2020 Earnings Call dated Nov. 02, 2020 Corporate Participants: Lisa M. Wilson -- Investor Relations - In-Site Communications,
AbbVie shares gain after Q3 results beat estimates: Infographic
AbbVie (NYSE: ABBV) reported third-quarter 2020 financial results before the regular trading hours on Friday. The pharmaceutical behemoth reported Q3 revenue of
Infographic: Highlights of Gilead Sciences (GILD) Q3 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) Wednesday said its third-quarter earnings increased, aided by higher revenues. The results also exceeded the
Pfizer (PFE) posts mixed results in Q3
Pfizer Inc (NYSE: PFE) reported third-quarter 2020 financial results before the opening bell on Tuesday. The pharmaceutical giant reported a 4% decline
Infographic: Highlights of Merck & Co. (MRK) Q3 2020 earnings report
Merck & Co., Inc. (NYSE: MRK) reported stronger than expected earnings and sales for the third quarter of 2020. The company's stock
Biogen Inc. (BIIB) Q3 2020 Earnings Call Transcript
Biogen Inc. (NASDAQ: BIIB) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Joe Mara -- Head of Investor Relations Michel Vounatsos -- Chief Executive Officer
Earnings: Intuitive Surgical (ISRG) Q3 results exceed estimates
Intuitive Surgical Inc. (NASDAQ: ISRG) reported lower earnings and revenues for the third quarter of 2020, hurt by the coronavirus-related disruption. However,
Johnson & Johnson (JNJ) Q3 earnings: Infographic
Johnson & Johnson (NYSE: JNJ) reported third-quarter 2020 financial results before the opening bell on Tuesday. The pharmaceutical giant reported a 2%
AstraZeneca stock looks a good bet as COVID antibody drug brings fresh hope
With the pandemic situation showing little signs of improvement, healthcare institutions are under pressure to expedite their vaccine development programs, amid growing
UnitedHealth Group (UNH) is headed for a weak second half. Here’s why
For UnitedHealth Group Inc. (NYSE: UNH), the early effect of coronavirus on its business was a marked reduction in costs due to
Bristol Myers looks to expand cardiovascular portfolio with MyoKardia acquisition
Bristol Myers Squibb (NYSE: BMY) agreed to acquire MyoKardia Inc. (NASDAQ: MYOK) for $13.1 billion in cash. The deal, which amounts to